Addex Therapeutics (ADXN) Net Margin (2019 - 2025)
Addex Therapeutics' Net Margin was -740720.56% in Q4 2025, down 660764.60 percentage points from -79955.97% a year earlier and down 735414.31 percentage points from the prior quarter.
Powered by 
Analysis
Addex Therapeutics (ADXN) Net Margin (2019 - 2025) Analysis & Trends
For FY2025, Net Margin at Addex Therapeutics came in at -22448.44%, down 24194.48 percentage points from FY2024.
- Net Margin shows a five-year change of -22092.52 percentage points (FY2020 to FY2025).
- In earlier years, Net Margin was 1746.04% in FY2024 (+2400.51 pp), -654.47% in FY2023 (+808.11 pp), -1462.57% in FY2022 (-936.16 pp) and -526.42% in FY2021 (-170.50 pp).
- The Q4 2025 figure marks the lowest quarterly Net Margin in data going back to Q1 2019.
- Compared with a year earlier, Net Margin was higher in 1 of the last six quarters, with an average year-over-year change of -122102.04 percentage points.
- The best year-over-year quarter for Net Margin over five years was Q3 2021 (a gain of 11623.99 percentage points); the worst was Q4 2025 (a drop of 660764.60 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.48 Bn | 1,106.07 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 618.81 Bn | 537.34 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 502.02 Bn | 475.14 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 297.87 Bn | 261.86 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 236.67 Bn | 192.07 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.16 Bn | 165.36 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 169.69 Bn | 116.34 Bn | 10.94 Bn | -1.65% |
| 10 | Addex Therapeutics | 5.10 Mn | -1.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -740,720.56% |
| Sep 30, 2025 | -5,306.25% |
| Dec 31, 2024 | -79,955.97% |
| Sep 30, 2024 | -2,841.86% |
| Jun 30, 2024 | 11,171.90% |
| Mar 31, 2024 | -1,322.23% |
| Dec 31, 2023 | 746.17% |
| Sep 30, 2023 | -798.52% |
| Jun 30, 2023 | -424.04% |
| Mar 31, 2023 | -480.54% |
| Dec 31, 2022 | 829.30% |
| Sep 30, 2022 | -1,003.38% |
| Jun 30, 2022 | -3,938.42% |
| Mar 31, 2022 | -2,454.93% |
| Dec 31, 2021 | 536.98% |
| Sep 30, 2021 | -527.56% |
| Jun 30, 2021 | -472.51% |
| Mar 31, 2021 | -312.71% |
| Dec 31, 2020 | 376.64% |
| Sep 30, 2020 | -12,151.56% |
API Access
Addex Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ADXN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ADXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ADXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();